Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 137

1.

Ethnic differences in acute heart failure outcomes in Ontario.

Sun LY, Kimmoun A, Takagi K, Liu PP, Bader Eddeen A, Mebazaa A.

Int J Cardiol. 2019 Sep 15;291:177-182. doi: 10.1016/j.ijcard.2019.05.043. Epub 2019 May 22.

PMID:
31153653
2.

Dilated cardiomyopathy.

Schultheiss HP, Fairweather D, Caforio ALP, Escher F, Hershberger RE, Lipshultz SE, Liu PP, Matsumori A, Mazzanti A, McMurray J, Priori SG.

Nat Rev Dis Primers. 2019 May 9;5(1):32. doi: 10.1038/s41572-019-0084-1. Review.

PMID:
31073128
3.

Biomarkers in the Diagnosis, Management, and Prognostication of Perioperative Right Ventricular Failure in Cardiac Surgery-Are We There Yet?

Jabagi H, Mielniczuk LM, Liu PP, Ruel M, Sun LY.

J Clin Med. 2019 Apr 25;8(4). pii: E559. doi: 10.3390/jcm8040559. Review.

4.

Innate Immune Signaling and Its Role in Metabolic and Cardiovascular Diseases.

Xu M, Liu PP, Li H.

Physiol Rev. 2019 Jan 1;99(1):893-948. doi: 10.1152/physrev.00065.2017. Review.

PMID:
30565509
5.

Utility of Novel Cardiorenal Biomarkers in the Prediction and Early Detection of Congestive Kidney Injury Following Cardiac Surgery.

Zelt JGE, Mielniczuk LM, Liu PP, Dupuis JY, Chih S, Akbari A, Sun LY.

J Clin Med. 2018 Dec 12;7(12). pii: E540. doi: 10.3390/jcm7120540.

6.

Disability-free survival after coronary artery bypass grafting in women and men with heart failure.

Sun LY, Tu JV, Lee DS, Beanlands RS, Ruel M, Austin PC, Eddeen AB, Liu PP.

Open Heart. 2018 Nov 5;5(2):e000911. doi: 10.1136/openhrt-2018-000911. eCollection 2018.

7.

Diagnosing hypertension in Indigenous Canadians (DREAM-GLOBAL): A randomized controlled trial to compare the effectiveness of short message service messaging for management of hypertension: Main results.

Tobe SW, Yeates K, Campbell NRC, Maar MA, Perkins N, Liu PP, Sleeth J, McAllister C, Hua-Stewart D, Wells G, Bernick J.

J Clin Hypertens (Greenwich). 2019 Jan;21(1):29-36. doi: 10.1111/jch.13434. Epub 2018 Nov 26.

8.

Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update.

Tobe SW, Stone JA, Anderson T, Bacon S, Cheng AYY, Daskalopoulou SS, Ezekowitz JA, Gregoire JC, Gubitz G, Jain R, Keshavjee K, Lindsay P, L'Abbe M, Lau DCW, Leiter LA, O'Meara E, Pearson GJ, Rabi DM, Sherifali D, Selby P, Tu JV, Wharton S, Walker KM, Hua-Stewart D, Liu PP.

CMAJ. 2018 Oct 9;190(40):E1192-E1206. doi: 10.1503/cmaj.180194. No abstract available.

9.

Prevalence and Long-Term Survival After Coronary Artery Bypass Grafting in Women and Men With Heart Failure and Preserved Versus Reduced Ejection Fraction.

Sun LY, Tu JV, Bader Eddeen A, Liu PP.

J Am Heart Assoc. 2018 Jun 16;7(12). pii: e008902. doi: 10.1161/JAHA.118.008902.

10.

N-Terminal Pro B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T Levels Are Related to the Extent of Hibernating Myocardium in Patients With Ischemic Heart Failure.

Zelt JGE, Liu PP, Erthal F, deKemp RA, Wells G, O'Meara E, Garrard L, Beanlands RSB, Mielniczuk LM.

Can J Cardiol. 2017 Nov;33(11):1478-1488. doi: 10.1016/j.cjca.2017.06.012. Epub 2017 Jun 27.

PMID:
28966019
11.

Erratum to: Disruption of mindin exacerbates cardiac hypertrophy and fibrosis.

Bian ZY, Wei X, Deng S, Tang QZ, Feng J, Zhang Y, Liu C, Jiang DS, Yan L, Zhang LF, Chen M, Fassett J, Chen Y, He YW, Yang Q, Liu PP, Li H.

J Mol Med (Berl). 2017 Nov;95(11):1251-1253. doi: 10.1007/s00109-017-1588-3. No abstract available.

PMID:
28856378
12.

Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association.

Chow SL, Maisel AS, Anand I, Bozkurt B, de Boer RA, Felker GM, Fonarow GC, Greenberg B, Januzzi JL Jr, Kiernan MS, Liu PP, Wang TJ, Yancy CW, Zile MR; American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology; Council on Basic Cardiovascular Sciences; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Epidemiology and Prevention; Council on Functional Genomics and Translational Biology; and Council on Quality of Care and Outcomes Research.

Circulation. 2017 May 30;135(22):e1054-e1091. doi: 10.1161/CIR.0000000000000490. Epub 2017 Apr 26. Review. Erratum in: Circulation. 2017 Nov 7;136(19):e345.

PMID:
28446515
13.

Applications of 3D printing in cardiovascular diseases.

Giannopoulos AA, Mitsouras D, Yoo SJ, Liu PP, Chatzizisis YS, Rybicki FJ.

Nat Rev Cardiol. 2016 Dec;13(12):701-718. doi: 10.1038/nrcardio.2016.170. Epub 2016 Oct 27. Review.

PMID:
27786234
14.

Identifying Low-Abundance Biomarkers: Aptamer-Based Proteomics Potentially Enables More Sensitive Detection in Cardiovascular Diseases.

Gramolini A, Lau E, Liu PP.

Circulation. 2016 Jul 26;134(4):286-9. doi: 10.1161/CIRCULATIONAHA.116.022940. No abstract available.

PMID:
27444931
15.

Long Noncoding RNAs in the Heart: The Regulatory Roadmap of Cardiovascular Development and Disease.

Rayner KJ, Liu PP.

Circ Cardiovasc Genet. 2016 Apr;9(2):101-3. doi: 10.1161/CIRCGENETICS.116.001413. No abstract available.

PMID:
27094196
16.

Wild-Type Transthyretin Amyloid Cardiomyopathy: A Missed Cause of Heart Failure With Preserved Ejection Fraction With Evolving Treatment Implications.

Liu PP, Smyth D.

Circulation. 2016 Jan 19;133(3):245-7. doi: 10.1161/CIRCULATIONAHA.115.020351. Epub 2015 Dec 11. No abstract available.

PMID:
26660283
17.

Evolutionarily conserved intercalated disc protein Tmem65 regulates cardiac conduction and connexin 43 function.

Sharma P, Abbasi C, Lazic S, Teng ACT, Wang D, Dubois N, Ignatchenko V, Wong V, Liu J, Araki T, Tiburcy M, Ackerley C, Zimmermann WH, Hamilton R, Sun Y, Liu PP, Keller G, Stagljar I, Scott IC, Kislinger T, Gramolini AO.

Nat Commun. 2015 Sep 25;6:8391. doi: 10.1038/ncomms9391.

PMID:
26403541
18.

Pharmacologic Options for the Management of Systolic Heart Failure: Examining Underlying Mechanisms.

Mancini GB, Howlett JG, Borer J, Liu PP, Mehra MR, Pfeffer M, Swedberg K, Tardif JC.

Can J Cardiol. 2015 Oct;31(10):1282-92. doi: 10.1016/j.cjca.2015.02.013. Epub 2015 Feb 19. Review.

PMID:
26095932
19.

Metformin increases degradation of phospholamban via autophagy in cardiomyocytes.

Teng AC, Miyake T, Yokoe S, Zhang L, Rezende LM Jr, Sharma P, MacLennan DH, Liu PP, Gramolini AO.

Proc Natl Acad Sci U S A. 2015 Jun 9;112(23):7165-70. doi: 10.1073/pnas.1508815112. Epub 2015 May 26.

20.

Role of innate and adaptive immune mechanisms in cardiac injury and repair.

Epelman S, Liu PP, Mann DL.

Nat Rev Immunol. 2015 Feb;15(2):117-29. doi: 10.1038/nri3800. Review.

Supplemental Content

Loading ...
Support Center